Literature DB >> 14762885

Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients.

Marcy A List1, Judith Lee Rutherford, John Stracks, Barbara Roa Pauloski, Jerilyn A Logemann, Donna Lundy, Paula Sullivan, William Goodwin, Merrill Kies, Everett E Vokes.   

Abstract

BACKGROUND: Treatment decisions in head and neck cancer (HNC) might involve consideration of uncertain tradeoffs of one late effect against another or increasing toxicity or residual impairment for increased chance of survival. Understanding how patients prioritize potential outcomes, as well as whether these preferences are similar to those of nonpatients, is important to informed decision making and treatment planning.
METHODS: Two hundred forty-seven newly diagnosed HNC patients from nine institutions and 131 nonpatients rank ordered a set of 12 potential treatment outcomes (eg, cure; being able to swallow; normal voice) from highest (1) to lowest (12).
RESULTS: Patients and nonpatients were similar with respect to the three items most frequently ranked in the top three, that is, "being cured of cancer," "living as long as possible," and "having no pain" in that order. In contrast, patients more frequently ranked "cure" (90% vs 80%) and less frequently ranked "no pain" (34% vs 52%) in the top three.
CONCLUSIONS: Survival seems to be of paramount importance to both patient and nonpatient groups, overshadowing associated toxicities and potential dysfunction. At the same time, patients might be more willing than nonpatients to undergo aggressive treatments and endure acute distress in the interest of potential long-term gains (ie, cure or longer survival). Copyright 2004 Wiley Periodicals, Inc. Head Neck 26: 163-170, 2004

Entities:  

Mesh:

Year:  2004        PMID: 14762885     DOI: 10.1002/hed.10367

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  17 in total

Review 1.  Endpoints and cutpoints in head and neck oncology trials: methodical background, challenges, current practice and perspectives.

Authors:  Marcus Hezel; Kathrin von Usslar; Thiemo Kurzweg; Balazs B Lörincz; Rainald Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-09       Impact factor: 2.503

Review 2.  Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

Authors:  Melina J Windon; Gypsyamber D'Souza; Carole Fakhry
Journal:  Future Oncol       Date:  2018-09-28       Impact factor: 3.404

3.  [Dose de-escalation during adjuvant chemoradiotherapy of HPV-associated oropharyngeal squamous cell carcinoma: the MC1273 phase II study].

Authors:  Alexander Rühle; Nils H Nicolay
Journal:  Strahlenther Onkol       Date:  2019-12       Impact factor: 3.621

4.  Priorities of head and neck cancer patients: a patient survey based on the brief ICF core set for HNC.

Authors:  Uta Tschiesner; Carla Sabariego; Elisabeth Linseisen; Sven Becker; Marita Stier-Jarmer; Alarcos Cieza; Ulrich Harreus
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-31       Impact factor: 2.503

5.  Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment.

Authors:  Melina J Windon; Carole Fakhry; Farhoud Faraji; Tanya Troy; Christine G Gourin; Ana P Kiess; Wayne Koch; David W Eisele; Gypsyamber D'Souza
Journal:  Oral Oncol       Date:  2019-06-04       Impact factor: 5.337

6.  Patient Reflections on Decision Making for Laryngeal Cancer Treatment.

Authors:  Andrew G Shuman; Knoll Larkin; Dorothy Thomas; Frank L Palmer; Joseph J Fins; Shrujal S Baxi; Nancy Lee; Jatin P Shah; Angela Fagerlin; Snehal G Patel
Journal:  Otolaryngol Head Neck Surg       Date:  2017-01-24       Impact factor: 3.497

7.  Priorities, concerns, and regret among patients with head and neck cancer.

Authors:  Melina J Windon; Gypsyamber D'Souza; Farhoud Faraji; Tanya Troy; Wayne M Koch; Christine G Gourin; Ana P Kiess; Karen T Pitman; David W Eisele; Carole Fakhry
Journal:  Cancer       Date:  2019-01-15       Impact factor: 6.860

8.  Quality of life in head and neck cancers patients: predictive factors, functional and psychosocial outcome.

Authors:  E Babin; E Sigston; M Hitier; D Dehesdin; J P Marie; O Choussy
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-01-11       Impact factor: 2.503

9.  Survival and risk of adverse events in older patients receiving postoperative adjuvant chemotherapy for resected stages II-IIIA lung cancer: observational cohort study.

Authors:  Juan P Wisnivesky; Cardinale B Smith; Stuart Packer; Gary M Strauss; Linda Lurslurchachai; Alex Federman; Ethan A Halm
Journal:  BMJ       Date:  2011-07-14

10.  Surgery for Laryngopharyngeal SCC in the Era of Organ Preservation.

Authors:  Jean Louis Lefebvre
Journal:  Clin Exp Otorhinolaryngol       Date:  2009-12-31       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.